Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020.
burden of disease
influenza
non-influenza respiratory virus
risk factor
severity
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
medline:
21
7
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
ppublish
Résumé
BackgroundKnowledge on the burden attributed to influenza viruses vs other respiratory viruses in children hospitalised with severe acute respiratory infections (SARI) in Belgium is limited.AimThis observational study aimed at describing the epidemiology and assessing risk factors for severe disease.MethodsWe retrospectively analysed data from routine national sentinel SARI surveillance in Belgium. Respiratory specimens collected during winter seasons 2011 to 2020 were tested by multiplex real-time quantitative PCR (RT-qPCR) for influenza and other respiratory viruses. Demographic data and risk factors were collected through questionnaires. Patients were followed-up for complications or death during hospital stay. Analysis focused on children younger than 15 years. Binomial logistic regression was used to identify risk factors for severe disease in relation to infection status.ResultsDuring the winter seasons 2011 to 2020, 2,944 specimens met the study case definition. Complications were more common in children with underlying risk factors, especially asthma (adjusted risk ratio (aRR): 1.87; 95% confidence interval (CI): 1.46-2.30) and chronic respiratory disease (aRR: 1.88; 95% CI: 1.44-2.32), regardless of infection status and age. Children infected with non-influenza respiratory viruses had a 32% higher risk of complications (aRR: 1.32; 95% CI: 1.06-1.66) compared with children with influenza only.ConclusionMulti-virus testing in children with SARI allows a more accurate assessment of the risk of complications and attribution of burden to respiratory viruses beyond influenza. Children with asthma and respiratory disease should be prioritised for clinical care, regardless of their virological test result and age, and targeted for prevention campaigns.
Identifiants
pubmed: 37470740
doi: 10.2807/1560-7917.ES.2023.28.29.2300056
pmc: PMC10360368
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet Glob Health. 2020 Apr;8(4):e497-e510
pubmed: 32087815
Clin Infect Dis. 2003 Feb 1;36(3):299-305
pubmed: 12539071
J Infect Dis. 2020 Aug 17;222(6):979-988
pubmed: 32320465
Eur Respir J. 2011 Jan;37(1):44-52
pubmed: 20530036
Lancet Microbe. 2021 Mar;2(3):e105-e114
pubmed: 33937883
Pediatrics. 2016 Sep;138(3):
pubmed: 27535144
J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):86-89
pubmed: 28444226
Influenza Other Respir Viruses. 2018 Nov;12(6):780-792
pubmed: 29858537
Eur Respir J. 2017 Sep 27;50(3):
pubmed: 28954782
Pediatr Infect Dis J. 2020 Jun;39(6):489-493
pubmed: 32091502
Clin Microbiol Infect. 2021 Apr;27(4):631.e1-631.e6
pubmed: 32540470
JAMA. 2005 Nov 2;294(17):2188-94
pubmed: 16264160
Lancet Reg Health Am. 2022 Sep;13:None
pubmed: 36189114
Epidemiol Infect. 2014 Sep;142(9):1826-35
pubmed: 24229618
Euro Surveill. 2020 Oct;25(39):
pubmed: 33006303
Emerg Infect Dis. 2004 Jun;10(6):1095-101
pubmed: 15207063
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Nat Rev Dis Primers. 2018 Jun 28;4(1):3
pubmed: 29955068
PLoS One. 2019 Jan 11;14(1):e0210353
pubmed: 30633778
BMC Infect Dis. 2015 Nov 14;15:515
pubmed: 26567015
BMC Infect Dis. 2020 Oct 19;20(1):769
pubmed: 33076855
Sci Rep. 2021 Mar 4;11(1):5163
pubmed: 33664311
Korean J Pediatr. 2014 Jan;57(1):29-34
pubmed: 24578714
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552